No Detail Found!

Recombinant Activated Factor Vii: a Savior in Management of Postpartum Hemorrhage.

Author(s)
Shashi Kiran Department of Anesthesiology & Critical Care, Pt. B. D. Sharma University of Health Sciences, Haryana, India
Teena Bansal Department of Anesthesiology & Critical Care, Pt. B. D. Sharma University of Health Sciences, Haryana, India
Abstract
Bleeding, a major cause of morbidity and mortality, is one of the most difficult challenges for obstetricians and anesthesiologists. The management of major obstetric hemorrhage is challenging resulting in surgical and medical interventions, sometimes requiring hysterectomy. Use of Recombinant activated factor VII r(FVIIa) is a recent advancement in the control of PPH. In situations of intractable PPH, where primary measures to control hemorrhage fail, administration of rFVIIa should be considered before decision to perform a hysterectomy is undertaken. We hereby present a case report of a 21 year female presenting with post caesarean PPH refractory to standard therapy , managed successfully by rFVIIa.
Publication Details
Page(s) 227-229
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 20, Issue: 2, Year: 2016

Request the full text from PASTIC

References
MagonN,BabuKM, 2012.Recombinant Factor VIIa in post-partum haemorrhage: a new weapon in Obstetrician's Armamentarium,N Am J med Sci 10 94938 -62
LusherJM,RobertsHR,DavignonG,JoistJH,SmithH,ShapiroA,FongJ,GurewitschED,KangHJ,KumpL,MackPF, 2007.An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery,Anesth Analg 104 666 -72
ChaudhryS,AliF,KhanAW,AslamA,SultanG, .Recombinant factor VII (rFVII) can be useful for massive hemorrhage 5, -
2015.during radical nephrectomy,Anaesth, pain & intensive care 19 170 -2
MurakamiM,KobayashiT,KuboT,HataT,TakedaS,MasuzakiH, 2015.Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by perinatology committee, Japan society of obstetrics and gynecology,J Obstet Gynaecol Res 10 1161 -8
HoffmanM,MonroeDM,RobertsHR,FranchiniM,LippiG,FranchiM., 2007.The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage,BJOG 114 8 -15
GhodkiPS,SardesaiSP, 2014.Obstetric hemorrhage: anesthetic implications and management,Anaesth, pain & intensive care 18 405 -14
IsmailS.,FranchiniM,FranchiM,BergaminiV,SalvagnoGL,MontagnanaM,LippiG.,MartinowitzU,MichaelsonM, 2005.Israeli Multidisciplinary rFVIIa Task Force. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding. a report by the Israeli Multidisciplinary rFVIIa Task Force,J Thromb Haemost 3 640 -8
0

Citations

0

Downloads

48

Views